Literature DB >> 10960362

PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues.

W Kong1, G P Swain, S Li, R H Diamond.   

Abstract

The mechanisms controlling tyrosine phosphorylation of cellular proteins are important in the regulation of many cellular processes, including development and differentiation. Protein tyrosine phosphatases (PTPases) may be as important as protein tyrosine kinases (PTKs) in these processes. PRL-1 is a distinct PTPase originally identified as an immediate-early gene in liver regeneration whose expression is associated with growth in some tissues but with differentiation in others. We now demonstrate that the PRL-1 protein is expressed during development in a number of digestive epithelial tissues. It is expressed at variable time points in the developing intestine, but its expression is limited to the developing villus enterocytes. In the gastric epithelium, PRL-1 expression in the adult is restricted to zymogen cells. PRL-1 is also expressed in the developing liver and esophagus and in the epithelia of the kidney and lung. In each of these contexts, the expression of PRL-1 is associated with terminal differentiation, suggesting that it may play a role in this important developmental process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960362     DOI: 10.1152/ajpgi.2000.279.3.G613

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  9 in total

1.  Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues.

Authors:  Carmen M Dumaual; George E Sandusky; Pamela L Crowell; Stephen K Randall
Journal:  J Histochem Cytochem       Date:  2006-09-06       Impact factor: 2.479

2.  Localizing PRL-2 expression and determining the effects of dietary Mg(2+) on expression levels.

Authors:  Jeremy Gungabeesoon; Michel L Tremblay; Noriko Uetani
Journal:  Histochem Cell Biol       Date:  2016-03-25       Impact factor: 4.304

3.  Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma.

Authors:  J-W Lu; J-G Chang; K-T Yeh; R-M Chen; J J P Tsai; W-W Su; R-M Hu
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

4.  1H, 13C and 15N resonance assignments and secondary structure of the human protein tyrosine phosphatase, PRL-2.

Authors:  Hongjun Zhou; Marijo Gallina; Hongyuan Mao; Daniel Nietlispach; Stephen F Betz; Jacquelyn S Fetrow; Peter J Domaille
Journal:  J Biomol NMR       Date:  2003-12       Impact factor: 2.835

5.  Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.

Authors:  Andria L Skinner; Anthony A Vartia; Todd D Williams; Jennifer S Laurence
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

6.  Increased phosphatase regenerating liver-1 trigger vascular remodeling in injured ovary via platelet-derived growth factor signaling pathway.

Authors:  Hyeri Park; Jin Seok; Jun Hyeong You; Jae Yeon Kim; Ja-Yun Lim; Gi Jin Kim
Journal:  Stem Cell Res Ther       Date:  2022-03-07       Impact factor: 6.832

7.  Expression of phosphatase of regenerating liver family genes during embryogenesis: an evolutionary developmental analysis among Drosophila, amphioxus, and zebrafish.

Authors:  Ming-Der Lin; Hsun-Tzu Lee; Szu-Chieh Wang; Han-Ru Li; Hsin-Lun Hsien; Kai-Wen Cheng; Yu-Di Chang; Min-Lang Huang; Jr-Kai Yu; Yau-Hung Chen
Journal:  BMC Dev Biol       Date:  2013-05-04       Impact factor: 1.978

8.  Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene.

Authors:  Krystle T Pagarigan; Bryce W Bunn; Jake Goodchild; Travis K Rahe; Julie F Weis; Leslie J Saucedo
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  Analysis of molecular determinants of PRL-3.

Authors:  Mihaela Pascaru; Carmen Tanase; Andrei M Vacaru; Patricia Boeti; Elena Neagu; Irinel Popescu; Stefan E Szedlacsek
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.